About Cancer Immunology Research
Scope
Cancer Immunology Research publishes outstanding original articles reporting major advances that span the discipline of cancer immunology, from basic investigations of host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and in-depth analysis of late-stage clinical trials. The journal also publishes reviews and opinion pieces of broad significance across the spectrum of cancer immunology research. As the premier resource for disseminating knowledge of immunology to the cancer research community, the journal catalyzes cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.
Specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and immunologically insightful clinical investigations.
Manuscript Submission
Cancer Immunology Research welcomes submission of original research, review articles, perspectives, commentaries, and letters to the editor. For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.
The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Instructions for Authors. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting. Authors should be familiar with these instructions prior to submitting their work to the journal.
Manuscripts are stringently reviewed for high standards of scientific merit, and only those articles that report results of novel, timely, and broadly significant research are accepted for publication.
Submit your article to Cancer Immunology Research 
Presubmission Inquiries
Cancer Immunology Research welcomes presubmission inquiries. To inquire about your manuscript’s suitability for the journal prior to formal submission, send an email directly to the editors at cancerimmunolres@aacr.org. Presubmission inquiries pertaining to original research should contain a brief description of the study and its significance, the article abstract, and any prepared figures. Presubmission inquiries pertaining to review or commentary pieces should contain an outline or draft, if available. The editors endeavor to respond within 3 business days.
Journal Metrics
For detailed metrics about Cancer Immunology Research and the other AACR journals see AACR Journals Metrics.
Editors and Editorial Board
Editorial oversight of Cancer Immunology Research and decisions on manuscripts submitted to the journal are the responsibility of the Editors-in-Chief and Executive Editor. See Editorial Board for more information.
Copyright, Permissions and Access
Material published in Cancer Immunology Research is covered and protected by copyright. Authors who wish to publish articles and other material in AACR journals must formally transfer copyright to the AACR. The final typeset version of every published article is rendered freely accessible 12 months after publication. Authors who prefer for their article to be immediately freely accessible online may make this selection by paying an additional fee through the AACR AuthorChoice option. In addition, the AACR assists authors in satisfying major funder Open Access archiving mandates by depositing the accepted author version of their article in a designated public repository. For additional details about all these topics, see Copyright, Permissions and Access
Publication Fees
To defray publication costs and to support other AACR programs, publication in Cancer Immunology Research involves the payment of a fixed publication fee and an additional fee for any color figures. If no financial support exists, authors may apply for a waiver of the fixed publication fee at the time of submission. See Publication Fees for further details.
Journal Information
Cancer Immunology Research is published by the AACR in collaboration with the Cancer Research Institute (CRI). The archives of CRI’s journal, Cancer Immunity (2010-2013), are housed on the Cancer Immunology Research website.
Cancer Immunology Research (CIR) (Print ISSN: 2326-6066; Online ISSN: 2326-6074) is a continuous online publication with a monthly print issue, one volume/year, by the American Association for Cancer Research, Inc. (AACR).
Cancer Immunology Research is abstracted and/or indexed in MEDLINE, Science Citation Index, Scopus, Web of Science, Biological Abstracts, and BIOSYS Previews®.
The journal is printed on paper that meets the requirements of ANSI/NISO Z39.48-1992 (Permanence of Paper).
Back Issues and Single Issue Sales
Subject to availability, single copies of Cancer Immunology Research may be purchased for $60 per copy in the U.S. or $65 per copy outside the U.S. For more information, contact:
AACR Publications Sales & Marketing Department
American Association for Cancer Research
615 Chestnut Street, 17th Floor
Philadelphia, PA 19106-4404
Phone: (215) 440-9300; or Toll Free: (855) 744-4667
Email: pubsales@aacr.org
Contact
Cancer Immunology Research Editorial Office
American Association for Cancer Research | Publications Division
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215) 440-9300 | Fax: (215) 446-7289 | E-mail: cancerimmunolres@aacr.org
